418 related articles for article (PubMed ID: 18564207)
21. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
Späh F
Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
[TBL] [Abstract][Full Text] [Related]
22. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis.
Kaye JA; Li L; Jick SS
Br J Dermatol; 2008 Sep; 159(4):895-902. PubMed ID: 18616778
[TBL] [Abstract][Full Text] [Related]
23. Comorbidities in psoriasis.
Christophers E
Clin Dermatol; 2007; 25(6):529-34. PubMed ID: 18021889
[TBL] [Abstract][Full Text] [Related]
24. Skin and bone: the pathogenetic relationship between psoriasis and psoriatic arthritis.
Ko JM; Qureshi AW
G Ital Dermatol Venereol; 2010 Jun; 145(3):393-406. PubMed ID: 20461047
[TBL] [Abstract][Full Text] [Related]
25. Psoriasis and its comorbidities.
Onumah N; Kircik LH
J Drugs Dermatol; 2012 May; 11(5 Suppl):s5-10. PubMed ID: 22644770
[TBL] [Abstract][Full Text] [Related]
26. Psoriasis and systemic inflammation: underdiagnosed enthesopathy.
Girolomoni G; Gisondi P
J Eur Acad Dermatol Venereol; 2009 Sep; 23 Suppl 1():3-8. PubMed ID: 19686379
[TBL] [Abstract][Full Text] [Related]
27. Psoriasis--a systemic inflammatory disorder: clinic, pathogenesis and therapeutic perspectives.
Boehncke WH; Sterry W
J Dtsch Dermatol Ges; 2009 Nov; 7(11):946-52. PubMed ID: 19341429
[TBL] [Abstract][Full Text] [Related]
28. [Correlation between psoriasis and cardiovascular diseases (author's transl)].
Török L; Tóth E; Bruncsák A
Z Hautkr; 1982 May; 57(10):734-9. PubMed ID: 7102023
[TBL] [Abstract][Full Text] [Related]
29. Psoriasis, the liver, and the gastrointestinal tract.
Gisondi P; Del Giglio M; Cozzi A; Girolomoni G
Dermatol Ther; 2010; 23(2):155-9. PubMed ID: 20415823
[TBL] [Abstract][Full Text] [Related]
30. [Psoriasis as an independent risk factor for development of coronary artery disease].
Papo D; Hein R; Ring J
Dtsch Med Wochenschr; 2010 Sep; 135(36):1749-54. PubMed ID: 20812162
[TBL] [Abstract][Full Text] [Related]
31. Research gaps in psoriasis: opportunities for future studies.
Ryan C; Korman NJ; Gelfand JM; Lim HW; Elmets CA; Feldman SR; Gottlieb AB; Koo JY; Lebwohl M; Leonardi CL; Van Voorhees AS; Bhushan R; Menter A
J Am Acad Dermatol; 2014 Jan; 70(1):146-67. PubMed ID: 24126079
[TBL] [Abstract][Full Text] [Related]
32. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes M; Robinson D; Bala M; Kimball AB
J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
[TBL] [Abstract][Full Text] [Related]
33. Psoriasis: the visible killer.
Torres T; Bettencourt N
Rev Port Cardiol; 2014 Feb; 33(2):95-9. PubMed ID: 24525359
[TBL] [Abstract][Full Text] [Related]
34. [What's new in dermatological research?].
Dereure O
Ann Dermatol Venereol; 2009 Dec; 136 Suppl 7():S407-16. PubMed ID: 20110056
[TBL] [Abstract][Full Text] [Related]
35. Practical considerations in future psoriasis therapies.
Riddle C; Young M; Menter A
Dermatol Clin; 2004 Oct; 22(4):487-92, x. PubMed ID: 15450344
[TBL] [Abstract][Full Text] [Related]
36. More than skin-deep: the many dimensions of the psoriatic disease.
Boehncke WH; Boehncke S
Swiss Med Wkly; 2014; 144():w13968. PubMed ID: 24764145
[TBL] [Abstract][Full Text] [Related]
37. Psoriasis as the marker of underlying systemic disease.
Kourosh AS; Miner A; Menter A
Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
[TBL] [Abstract][Full Text] [Related]
38. Oral L-arginine supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass.
Lucotti P; Monti L; Setola E; La Canna G; Castiglioni A; Rossodivita A; Pala MG; Formica F; Paolini G; Catapano AL; Bosi E; Alfieri O; Piatti P
Metabolism; 2009 Sep; 58(9):1270-6. PubMed ID: 19592054
[TBL] [Abstract][Full Text] [Related]
39. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy.
Su YS; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):876-83. PubMed ID: 22702656
[TBL] [Abstract][Full Text] [Related]
40. Myocardial perfusion is preserved in patients with psoriasis without clinically evident cardiovascular disease.
Yalcin H; Balci DD; Ucar E; Ozcelik N; Tasci C; Seyfeli E; Akgul F; Yalcin F
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):798-802. PubMed ID: 19470047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
